PDB Short entry for 3E8O HEADER OXIDOREDUCTASE 20-AUG-08 3E8O TITLE CRYSTAL STRUCTURE OF A PUTATIVE ANTIBIOTIC BIOSYNTHESIS MONOOXYGENASE TITLE 2 (DR_2100) FROM DEINOCOCCUS RADIODURANS AT 1.40 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: UNCHARACTERIZED PROTEIN WITH FERREDOXIN-LIKE FOLD; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: DEINOCOCCUS RADIODURANS; SOURCE 3 ORGANISM_TAXID: 1299; SOURCE 4 GENE: NP_295823.1, DR_2100; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS PUTATIVE ANTIBIOTIC BIOSYNTHESIS MONOOXYGENASE, STRUCTURAL GENOMICS, KEYWDS 2 JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE KEYWDS 3 INITIATIVE, PSI-2, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 01-FEB-23 3E8O 1 REMARK SEQADV REVDAT 5 24-JUL-19 3E8O 1 REMARK LINK REVDAT 4 25-OCT-17 3E8O 1 REMARK REVDAT 3 28-JUL-10 3E8O 1 HEADER TITLE KEYWDS REVDAT 2 24-FEB-09 3E8O 1 VERSN REVDAT 1 09-SEP-08 3E8O 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PROTEIN OF UNKNOWN FUNCTION WITH JRNL TITL 2 FERREDOXIN-LIKE FOLD (NP_295823.1) FROM DEINOCOCCUS JRNL TITL 3 RADIODURANS AT 1.40 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0067 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 35326 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.130 REMARK 3 R VALUE (WORKING SET) : 0.128 REMARK 3 FREE R VALUE : 0.163 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1784 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.44 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2425 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.94 REMARK 3 BIN R VALUE (WORKING SET) : 0.1790 REMARK 3 BIN FREE R VALUE SET COUNT : 126 REMARK 3 BIN FREE R VALUE : 0.2220 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1536 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 16 REMARK 3 SOLVENT ATOMS : 271 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.44 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.08000 REMARK 3 B22 (A**2) : -0.34000 REMARK 3 B33 (A**2) : 0.34000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.30000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.062 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.056 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.033 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.877 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.978 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.970 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1621 ; 0.017 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 996 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2218 ; 1.626 ; 1.944 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2476 ; 1.747 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 217 ; 3.931 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 68 ;38.173 ;24.853 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 269 ;10.554 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 4 ;25.585 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 268 ; 0.096 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1823 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 295 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1029 ; 2.280 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 422 ; 1.177 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1651 ; 3.421 ; 4.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 592 ; 4.674 ; 6.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 559 ; 6.650 ; 8.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 2617 ; 1.974 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 289 ; 8.342 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 2579 ; 4.568 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. REMARK 3 3. EDO MOLECULE FROM THE CRYO SOLUTION IS MODELED. REMARK 3 4. AN UNKNOWN LIGAND (UNL) HAS BEEN MODELED IN THE PUTATIVE REMARK 3 ACTIVE SITE REMARK 4 REMARK 4 3E8O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-AUG-08. REMARK 100 THE DEPOSITION ID IS D_1000049014. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-AUG-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837,0.97916,0.97849 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 MONOCHROMATOR (HORIZONTAL REMARK 200 FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.2.5 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35346 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 29.814 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : 2.100 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 31.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.79 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2000M NAOAC, 30.0000% PEG-8000, 0.1M REMARK 280 CACODYLATE PH 6.5, VAPOR DIFFUSION,SITTING DROP,NANODROP, REMARK 280 TEMPERATURE 277K, VAPOR DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.81950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT CRYSTAL PACKING ANALYSIS SUGGESTS THE REMARK 300 ASSIGNMENT OF A DIMER AS THE SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 SER A 2 REMARK 465 PRO A 3 REMARK 465 GLN A 4 REMARK 465 SER A 5 REMARK 465 MSE A 6 REMARK 465 LEU A 7 REMARK 465 THR A 8 REMARK 465 SER A 9 REMARK 465 PRO A 10 REMARK 465 GLN A 11 REMARK 465 HIS A 12 REMARK 465 PRO A 13 REMARK 465 ARG A 14 REMARK 465 ARG A 15 REMARK 465 THR A 16 REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 465 SER B 2 REMARK 465 PRO B 3 REMARK 465 GLN B 4 REMARK 465 SER B 5 REMARK 465 MSE B 6 REMARK 465 LEU B 7 REMARK 465 THR B 8 REMARK 465 SER B 9 REMARK 465 PRO B 10 REMARK 465 GLN B 11 REMARK 465 HIS B 12 REMARK 465 PRO B 13 REMARK 465 ARG B 14 REMARK 465 ARG B 15 REMARK 465 THR B 16 REMARK 465 THR B 17 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 44 CG CD OE1 NE2 REMARK 470 GLU A 112 CG CD OE1 OE2 REMARK 470 GLN B 44 CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 47 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 63 87.77 -156.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNL A 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNL B 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 390777 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3E8O A 1 118 UNP Q9RSM4 Q9RSM4_DEIRA 1 118 DBREF 3E8O B 1 118 UNP Q9RSM4 Q9RSM4_DEIRA 1 118 SEQADV 3E8O GLY A 0 UNP Q9RSM4 EXPRESSION TAG SEQADV 3E8O GLY B 0 UNP Q9RSM4 EXPRESSION TAG SEQRES 1 A 119 GLY MSE SER PRO GLN SER MSE LEU THR SER PRO GLN HIS SEQRES 2 A 119 PRO ARG ARG THR THR MSE VAL ILE SER HIS GLY THR LEU SEQRES 3 A 119 SER ALA SER ALA GLU HIS ALA ALA HIS LEU ARG GLN LEU SEQRES 4 A 119 LEU VAL HIS ILE ALA GLN ALA THR ARG GLN GLU ASP GLY SEQRES 5 A 119 CYS LEU LEU TYR LEU VAL SER GLU ASP LEU SER GLN PRO SEQRES 6 A 119 GLY HIS PHE LEU ILE THR GLU HIS TRP ASP ASN LEU GLY SEQRES 7 A 119 ALA MSE HIS THR HIS LEU ALA LEU PRO GLY VAL THR GLN SEQRES 8 A 119 ALA ILE ASP ALA LEU LYS HIS LEU ASN VAL THR ASP LEU SEQRES 9 A 119 LYS ILE THR ALA TYR GLU ALA GLY GLU ALA ILE ASN ILE SEQRES 10 A 119 MSE GLY SEQRES 1 B 119 GLY MSE SER PRO GLN SER MSE LEU THR SER PRO GLN HIS SEQRES 2 B 119 PRO ARG ARG THR THR MSE VAL ILE SER HIS GLY THR LEU SEQRES 3 B 119 SER ALA SER ALA GLU HIS ALA ALA HIS LEU ARG GLN LEU SEQRES 4 B 119 LEU VAL HIS ILE ALA GLN ALA THR ARG GLN GLU ASP GLY SEQRES 5 B 119 CYS LEU LEU TYR LEU VAL SER GLU ASP LEU SER GLN PRO SEQRES 6 B 119 GLY HIS PHE LEU ILE THR GLU HIS TRP ASP ASN LEU GLY SEQRES 7 B 119 ALA MSE HIS THR HIS LEU ALA LEU PRO GLY VAL THR GLN SEQRES 8 B 119 ALA ILE ASP ALA LEU LYS HIS LEU ASN VAL THR ASP LEU SEQRES 9 B 119 LYS ILE THR ALA TYR GLU ALA GLY GLU ALA ILE ASN ILE SEQRES 10 B 119 MSE GLY MODRES 3E8O MSE A 18 MET SELENOMETHIONINE MODRES 3E8O MSE A 79 MET SELENOMETHIONINE MODRES 3E8O MSE A 117 MET SELENOMETHIONINE MODRES 3E8O MSE B 18 MET SELENOMETHIONINE MODRES 3E8O MSE B 79 MET SELENOMETHIONINE MODRES 3E8O MSE B 117 MET SELENOMETHIONINE HET MSE A 18 13 HET MSE A 79 8 HET MSE A 117 13 HET MSE B 18 8 HET MSE B 79 8 HET MSE B 117 13 HET UNL A 200 6 HET UNL B 200 6 HET EDO B 201 4 HETNAM MSE SELENOMETHIONINE HETNAM UNL UNKNOWN LIGAND HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 5 EDO C2 H6 O2 FORMUL 6 HOH *271(H2 O) HELIX 1 1 HIS A 31 ARG A 47 1 17 HELIX 2 2 ASN A 75 ALA A 84 1 10 HELIX 3 3 LEU A 85 LEU A 98 1 14 HELIX 4 4 SER B 28 ARG B 47 1 20 HELIX 5 5 ASN B 75 ALA B 84 1 10 HELIX 6 6 LEU B 85 HIS B 97 1 13 SHEET 1 A10 ILE A 114 MSE A 117 0 SHEET 2 A10 LYS B 104 GLU B 109 -1 O ALA B 107 N ILE A 114 SHEET 3 A10 VAL B 19 SER B 26 -1 N ILE B 20 O TYR B 108 SHEET 4 A10 HIS B 66 TRP B 73 -1 O PHE B 67 N LEU B 25 SHEET 5 A10 CYS B 52 ASP B 60 -1 N LEU B 56 O THR B 70 SHEET 6 A10 CYS A 52 ASP A 60 -1 N GLU A 59 O GLU B 59 SHEET 7 A10 HIS A 66 TRP A 73 -1 O HIS A 66 N ASP A 60 SHEET 8 A10 VAL A 19 SER A 26 -1 N LEU A 25 O PHE A 67 SHEET 9 A10 LYS A 104 GLU A 109 -1 O TYR A 108 N ILE A 20 SHEET 10 A10 ILE B 114 MSE B 117 -1 O MSE B 117 N ILE A 105 LINK C THR A 17 N MSE A 18 1555 1555 1.34 LINK C MSE A 18 N VAL A 19 1555 1555 1.31 LINK C ALA A 78 N MSE A 79 1555 1555 1.32 LINK C MSE A 79 N HIS A 80 1555 1555 1.32 LINK C ILE A 116 N MSE A 117 1555 1555 1.31 LINK C MSE A 117 N GLY A 118 1555 1555 1.33 LINK C MSE B 18 N VAL B 19 1555 1555 1.32 LINK C ALA B 78 N MSE B 79 1555 1555 1.33 LINK C MSE B 79 N HIS B 80 1555 1555 1.33 LINK C ILE B 116 N MSE B 117 1555 1555 1.33 LINK C MSE B 117 N GLY B 118 1555 1555 1.33 SITE 1 AC1 5 TYR A 55 GLU A 71 HIS A 82 ILE A 105 SITE 2 AC1 5 HOH A 231 SITE 1 AC2 6 ILE B 42 TYR B 55 GLU B 71 HIS B 82 SITE 2 AC2 6 ILE B 105 HOH B 225 SITE 1 AC3 7 THR B 24 ASP B 60 HIS B 66 PHE B 67 SITE 2 AC3 7 LEU B 68 HOH B 324 HOH B 330 CRYST1 33.715 59.639 47.511 90.00 97.18 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029660 0.000000 0.003735 0.00000 SCALE2 0.000000 0.016767 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021214 0.00000